Nearly all psychotropic drugs are metabolized by hepatic cytochrome P4
50-enzymes. In humans,there are 5 isoenzymes involved in this process.
The activity of these enzymes can be modulated by a number of commonl
y used drugs,yielding potentially hazardous interactions. Most of the
recently introduced selective serotonin reuptake inhibitors are potent
inhibitors of cytochrome P450 enzymes. Thus, the plasma concentration
s of tricyclic antidepressants or clozapine might be elevated into tox
ic levels. In contrast, carbamazepine induces most of the isoenzymes.
This potentiates the elimination of tricyclics and antipsychotics and
might cause a serious risk for the reccurence of depressive or psychot
ic symptoms. Moreover, 5-10% of the population are slow metabolizers o
f CYP2D6. This group is prone to increased adverse effects of moderate
ly dosed medication. This review systematically points out the reporte
d or predicted pharmacokinetic drug interactions in psychopharmacology
focussing on clinical significance.